Does CBD show up on a drug test?

What the tests are actually measuring

A cannabis drug test does not detect cannabis, and it does not detect CBD. It detects a specific molecule, and on the most common workplace test that molecule is not even THC itself but a metabolite of it, THC-COOH, which the body produces as it processes THC and which lingers far longer than the parent compound.

This is why the answer to the headline question is a firm no as far as CBD goes. Cannabidiol is structurally distinct, it is not what the antibodies in an immunoassay are raised against, and there is no routine test in UK employment screening designed to find it. If a product contains only CBD, there is nothing present for the test to react to.

The risk therefore has nothing to do with CBD and everything to do with what else is in the container. That reframes the whole question usefully: you are not asking whether CBD is detectable, you are asking whether the specific product you chose contains THC, how much, and whether the amount reaching you over time can cross a threshold set for a different purpose entirely.

One clarification on terminology, because two of the pages ranking for this question get it wrong in the same way. If a full spectrum product put THC into your system and a test then found THC, that is not a false positive. It is a true positive. The assay did exactly what it was built to do and correctly reported a substance that was really there. Calling it false suggests the test made a mistake, and framing it that way is how people talk themselves into believing the result can be explained away.

The number nobody else on this question prints

Here is what we found genuinely surprising while researching this page. We tore down the pages ranking for this question, including one running to roughly four and a half thousand words with thirteen frequently asked questions, and not one of them states the UK drug-driving limit. The longest of them explicitly declines to give a figure and points the reader at a different article.

That limit is the only number in this whole subject attached to a criminal offence, so here it is. Section 5A of the Road Traffic Act 1988 makes it an offence to drive with a specified controlled drug in your blood above a prescribed limit. For delta-9 THC that limit is 2 micrograms per litre of blood, set by the Drug Driving (Specified Limits) (England and Wales) Regulations 2014. Scotland introduced its own equivalent limits separately in 2019.

Now the part that changes how you should read every reassuring paragraph written about CBD and driving. Section 5A is a strict liability offence. The prosecution does not have to show you were impaired, or affected in any way, or that your driving was worse. Being over the limit is the offence. All the writing in this sector about how the amounts involved are too small to impair you is answering a question the law does not ask.

The consequences are not trivial either: a minimum twelve-month driving ban, an unlimited fine, and up to six months of imprisonment.

There is a statutory medical defence in section 5A, and it is narrower than people assume. It covers a drug that was prescribed or supplied for medical purposes and taken in accordance with the directions given. A CBD oil bought as a food supplement is not a prescribed medicine and was not supplied for medical purposes, so that defence does not reach it. If you are relying on the idea that you could explain a CBD product to a court, that is the provision you would be relying on, and it does not cover you.

Why nobody can tell you your personal risk

The obvious next question is how much of a full spectrum product it would take to cross the driving threshold, and the honest answer is that no one can tell you, including us. It is worth explaining why, because the reason is more useful than a fabricated number would be.

The two figures involved describe completely different things. The legal container ceiling is 1mg of controlled cannabinoids, which is a thousand micrograms, and it describes a quantity sitting in a pack. The driving threshold is 2 micrograms per litre of blood, which describes a concentration inside a person at a moment in time. An adult carries roughly five litres of blood.

Those units do not convert into each other, and anyone offering you an arithmetic bridge between them is guessing. Only a fraction of anything consumed ever appears in blood at once, and that fraction depends on the route, on what you ate, on your metabolism, on body composition, on how often you use the product and on how much has accumulated in tissue from previous use. Inhaled THC behaves quite differently from swallowed THC. There is no reliable dose-to-blood calculation to hand you.

What the comparison does establish is worth holding onto, though. A thousand micrograms permitted in a pack against a threshold of two micrograms per litre in a person are not numbers on the same scale, and the widespread implication that a legal container obviously holds too little THC to matter is an assumption rather than a finding. It might be right. Nobody in this search result has shown that it is.

So the honest caution, which is the whole point of this page: if you drive for a living, if losing your licence would upend your life, or if your employer screens, do not choose full spectrum and hope the numbers are on your side. Choose a grade with nothing controlled in it and remove the question.

Which grade actually removes the risk

The variable you control is not how much you use, it is what you buy, and the three extract grades sit in very different positions here.

Isolate contains CBD and nothing else. There is no THC present to find, no accumulation to worry about, and nothing for a screening assay to react to. For anyone who is tested, this is the straightforward choice and the reason isolate dominates gummies, drinks and most flavoured products.

Broad spectrum has had THC removed and should report as non-detected on a certificate. That is a strong position but it is a processing outcome rather than a structural guarantee, and non-detected always means non-detected at the testing laboratory's threshold. A batch certificate matters more here than the brand's reputation does.

Full spectrum retains THC deliberately. That is the definition of the grade, not a flaw in it, and a fully compliant container may hold up to the legal maximum. Regular use of a full spectrum product means repeated exposure to a small quantity of the exact compound every test in this article is designed to find, and THC-COOH is fat-soluble and accumulates with frequency of use rather than resetting between doses.

Two further routes to a positive result have nothing to do with your choice of grade, and both are worth knowing. Mislabelling is real: a product sold as broad spectrum whose certificate does not match, or which has no batch certificate at all, is an unknown rather than a safe choice. And cross-contamination in manufacturing can put trace THC into a product that was never meant to contain any. Neither is common with a well-documented brand, and neither is detectable by looking at the bottle.

Two figures being quoted at you that are wrong

While reading the pages ranking for this question we found two specific errors worth naming, because both would change how a reader assesses their own risk.

The first is a percentage. A major brand's UK site, on a page about drug testing, states that hemp-derived full spectrum products must legally contain a certain fraction of a per cent of THC or less. The figure quoted is the United States cultivation threshold, published on a page written for British readers, and it is not a UK consumer test of any kind. Ours is a fixed weight per container, and the difference is not cosmetic: a percentage scales with container size while a milligram ceiling does not.

The second is a daily intake figure. A UK retailer guide, dated 2026, advises readers to keep within an FSA limit of 70mg of CBD a day. The FSA replaced that figure with 10mg on 12 October 2023, so the advice is nearly three years out of date at the time of writing. This is the third page we have found during this run of research still publishing the retired number, which suggests it is propagating rather than fading.

Neither error is malicious. Both are what happens when a sector writes its guides by reading other guides. The practical lesson for a reader is the one this whole learn section keeps arriving at: check the date on the page, check whether the figure has a source, and be especially careful when a number sounds usefully permissive.

Competitive sport is a different regime again

If you compete under anti-doping rules, none of the workplace figures above apply to you, and the position is both clearer and stricter than most CBD writing suggests.

Cannabidiol was removed from the World Anti-Doping Agency's Prohibited List in 2018 and is not itself a prohibited substance. Every other cannabinoid, including THC, remains prohibited in competition, which means out-of-competition use is not the trigger but an in-competition sample is.

Delta-9 THC is unusual in having a urinary threshold rather than a straight prohibition, set at 150 ng/mL. That figure was raised from a far lower one in 2013 specifically to reduce findings caused by use outside competition, so it is more permissive than the workplace screening cut-offs discussed above rather than less. Above it, the laboratory reports an adverse finding regardless of when the substance was taken.

The principle underneath anti-doping enforcement is strict liability, exactly as it is under section 5A. An athlete is responsible for what is in their sample, and not knowing how it got there is not a defence in itself. In practice that puts a heavy weight on product documentation, and it is why supplement certification schemes exist at all.

The practical upshot is the same as everywhere else on this page. If you compete, choose a grade with nothing prohibited in it, keep the batch certificate, and take your governing body's guidance over any shop's, ours included.

If you are tested and it comes back positive

This is the section most guides skip, and it is the one that matters if the worst has already happened.

A screening test is not the final word. Immunoassay screening is designed to be sensitive rather than specific, and a positive screen is normally followed by confirmatory laboratory analysis using a different method, which is both more specific and more accurate. Ask whether confirmation was carried out, and on what method.

Gather your documentation. That means the product, the batch code on the pack, and the certificate of analysis covering that batch. A certificate showing a genuine container total is the only evidence you will have about what you actually consumed, which is precisely why buying products with obtainable batch certificates matters before anything goes wrong rather than after. We will supply the certificate for anything you bought from us on request.

Be realistic about what that evidence achieves, though. In an employment context it may support a conversation with occupational health, since policies vary and many employers distinguish between a compliant supplement and recreational use. In the driving context it achieves considerably less, because section 5A does not ask how the THC got there. A certificate explains your conduct; it does not create a defence.

And if you are in this position, the advice worth giving is not from a shop. Employment matters belong with your union or an employment adviser, and a section 5A charge belongs with a solicitor.

What is genuinely unsettled

Three honest gaps, none of which the confident writing on this subject acknowledges.

The first is the one already covered: there is no reliable way to convert a quantity in a container into a blood concentration in a person, so nobody can quantify individual risk from a compliant full spectrum product. The absence of that calculation is a real limit on what anyone, including a regulator, can currently tell you.

The second is cut-off variation. Screening thresholds are set by employers and by testing providers rather than by legislation, and they differ. A figure that is comfortably under one provider's threshold may not be under another's, and more sensitive assays have been moving thresholds downward. Any specific number in a guide, including the ones in our table, is a typical value rather than a rule.

The third is that the products themselves are a moving target. Full spectrum content varies between batches by its nature, the market's certificate practice is uneven, and the enforcement picture around large-format full spectrum products is unresolved. Our own worklist on obtaining current per-batch certificates for every full spectrum line we list is open rather than complete, which we would rather state than imply otherwise. This page was checked in July 2026.